KUALA LUMPUR: The Malaysian bio-trade and investment mission in conjunction with the 2014 BIO International Convention in San Diego resulted in seven exchanges of documents for collaboration in the biomedical and wellness industry.
A statement released by the Malaysian Biotechnology Corp (BiotechCorp) yesterday said the first exchange of documents was between Algae International Bhd (AIB) and Nutrigae to develop mutually beneficial programmes/projects to generate algae related products.
The second exchange was between Sengenics Sdn Bhd and CollabRx Inc to expand turnkey whole-exome clinical diagnostic services.
The third was between Neopeutics and Felda Wellness Corp, paving the way for the potential discovery of new therapeutic substances from traditional Malaysian medicine and Malaysian biodiversity for the international market.
Felda Wellness will also collaborate with Gordagen in a project aimed at extracting a new compound from palm oil to create products for exercise endurance, heart health and glycaemic control.
The fifth exchange of documents, involving Felda Wellness and Malaysian Genomics Resource Centre Bhd, is for a genome sequencing service for plants and a genetic screening service for humans known as Dtect, which screens DNA for known genetic markers associated with risks for diseases.
The delegation was led by Minister of Science, Technology and Innovation Datuk Dr Ewon Ebin. — Bernama
Did you find this article insightful?